No grinding, killing donkeys first: A new U.S. law limiting drug prices.

On Friday, President Trump signed four executive orders limiting drug prices: drug discounts, insulin/EpiPen, drug imports, and the International Drug Price Index.
drug discounts are a special mechanism in the United States, with PBM hired by insurance companies bargaining with wholesalers.
and EpiPen should have had cheap generics, but for a variety of reasons the price is high and has always been black.
and international drug price indices are related to higher U.S. drug prices than other developed countries, but drug prices in different countries are not easy to compare because of many complex factors.
This week many big drug company CEOs have said it's the wrong law, especially now that the pharmaceutical industry is enthusiastically developing new crown vaccines and drugs, digging the foot of a wall gives the impression that it's starting to kill donkeys before it's ready to go.
late last year, the House passed a new drug-price bill called HR3, saying it could save the U.S. government nearly $500 billion over 10 years.
House also introduced a price-cutting bill called HR19, but the chances of both bills passing both chambers into law are small.
this year marks the year of the general election and a once-in-a-century crown, so the issue of drug prices, the basic issue of people's health and spending, is once again a tool for politicians to move on.
of course, these decrees may also be subject to legal challenges, Congress will have different views, to what extent the implementation is not easy to say.
the United States has a problem with drug prices, drug prices are actually a problem affecting the world.
a few years ago there was a heartbreaking film in China called "I Am Not a Drug God" and a line called "There is only one disease in the world, poor."
You can't save it."
the same applies to the pharmaceutical industry.
consumers have no money to eat good medicine, pharmaceutical factories have no money to make good medicine.
there is no cheap new medicine in the world, this is a two-choice problem.
all policies to lower drug prices directly or indirectly affect the speed at which good drugs are found, and it is the most innovative and risky disruptive new drugs, such as PD-1, that are most likely to be affected.
look at the countries where disruptive drugs are made, you'll see that profit is the only driver of innovation.
but someone asked the price of the drug is now motionless on a hundred thousand a year is reasonable? It's like everyone thinks red meat is too expensive, collective shouting Laozi out 5 cents.
this does not reduce the price of red meat to 5 cents a serving, but only forces restaurants to sell only dumpling soup every day.
have asked why U.S. drug prices are much more expensive than all countries. This is because restaurants always ask Americans first what they want to eat, what you want to eat, what the world will have to do about American tastes.
americans can certainly choose to give up this power, consumers around the world can also give innovation free pricing, just to know the fundamental law of a penny a penny.
drugs and drugs are one thing, high-risk behavior driven by high profits.
is only the real money paid by drugs, drugs pay is the life of the family.
if white powder and cabbage a price, who will not take the risk to sell drugs, new drugs a truth.
imported drugs cheaply to obtain high-quality products at the same time imported inferior policies.
that limiting drug prices does not make good medicine able to everyone, but will result in no one using the best quality drugs that today's technology can bring. Tom Wolfe, a prominent
journalist, says America's prosperity is due to the fact that the United States is "most open country in the world, the most open one and all to compete-pell-mell for any great goal some" which is why dozens of new crown vaccines are now in contention.
if you admit that it's a reasonable investment to get the new crown vaccine on the market at such a cost, you should also know that every project in the pharmaceutical industry has patients waiting anxiously.
as to whether the U.S. government is now too big to begin intervening in drug prices, it is in line with the spirit of the constitution, because it has little to do with new drugs.
.